Journal of the International Alliance for Biological Standardization

Biologicals provides a modern and multidisciplinary international forum for news, debate, and original research on all aspects of biologicals used in human and veterinary medicine. The journal publishes original papers, reviews, and letters relevant to the development, production, quality control, and standardization of biological derived from both novel and established biotechnologies. Special issues are produced to reflect topics of particular international interest and concern.Three types of papers are welcome: original research reports, short papers, and review articles. The journal will also publish comments and letters to the editor, book reviews, meeting reports and information on regulatory issues.

Research Areas Include

Areas relevant to biologicals for human and veterinary use such as:


• Bacterial vaccines
• Blood products
• Cell biology
• Cell culture technology
• Cellular immunology
• Cytokines and allied mediators
• Diagnostics
• Downstream processing
• Gene transfer and expression
• General bacterology
• General virology, endogenous and adventitious viruses
• Hormones
• Immunochemistry
• Molecular biology
• Monoclonal antibodies
• Parasitology
• Prion and prion disease
• Protein chemistry
• Toxins
• Toxoids
• Viral vaccines

original research reports
short papers
review articles

Editor-in-Chief
R. Thorpe
Welwyn, UK
Section Editors
Blood Products
R. Seitz
Paul-Ehrlich-Institute, Langen, Germany
Biotherapeutics
M. Wadhwa
National Institute for Biological Standards and Control (NIBSC), Potters Bar, UK
Vaccines
I. Knezevic
World Health Organization (WHO), Geneva, Switzerland
E. Griffiths
Kingston-upon-Thames, UK
D. Smith
Health Canada, Ottawa, Ontario, Canada
Veterinary Sciences
D.M. Gatewood
EDGE Veterinary Vaccines Consulting Group, LLC, Ames, Iowa, USA
A.M. Brady
Gerrards Cross, UK
Reviews and Special Reports
R. Hill
U.S. Department of Agriculture (USDA), Ames, Iowa, USA
G. Vyas
University of California at San Francisco (UCSF), San Francisco, California, USA
Gene and Cell Therapy
L. Healy
The Francis Crick Institute, London, England, UK
Y. Zhao
National Institute for Biological Standards and Control (NIBSC), Potters Bar, Hertfordshire, UK
Editorial Board
T. B. Burnouf, PhD.
Taipei Medical University, Taipei, Taiwan
C. Chiu
University of California at San Francisco (UCSF), San Francisco, California, USA
N.E. Clough
U.S. Department of Agriculture (USDA), Ames, Iowa, USA
T. Hayakawa
Kinki University (Kindai), Osaka, Japan
S. Killian
University of South Dakota, Vermillion, South Dakota, USA
J. Löewer
Paul-Ehrlich-Institute, Langen, Germany
P.D. Minor
National Institute for Biological Standards and Control (NIBSC), Potters Bar, UK
G. Murano
San Francisco, CA, USA
Y. Omidi
Tabriz University of Medical Sciences, Iran
D. Onions
BioReliance Corporation, Rockville, Maryland, USA
T. Sandle
Bio Products Laboratory, Elstree, Hertfordshire, England, UK
R. Stebbings
Biological Safety Assessment, Cambridgeshire, UK